[Hypothalamic hamartoma in children]

Problemy Endokrinologii
|October 20, 2019
PubMed

Insights

This study examines children with precocious puberty (PP) caused by hypothalamic hamartomas. Medical treatment is highly effective for PP, while surgery carries significant risks and low efficacy.

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Neurology
  • Neuroscience

Context:

  • Hypothalamic hamartomas are rare brain malformations causing central precocious puberty (PP).
  • This study analyzes 27 pediatric cases, one of the largest series globally.
  • Understanding the relationship between hamartoma location and endocrine/neurologic symptoms is crucial.

Purpose:

  • To correlate specific hypothalamic hamartoma locations with distinct clinical manifestations, including central precocious puberty (PP).
  • To evaluate the efficacy and risks of surgical versus medical treatments for PP in children with hypothalamic hamartomas.

Summary:

  • Parahypothalamic (peduncular) hamartomas primarily cause PP.
  • Intrahypothalamic (sessile) hamartomas lead to PP and convulsive symptoms like laughter attacks.
  • Suprahypothalamic lesions are associated with diencephalic disorders such as obesity and diabetes insipidus.
  • Medical treatment using gonadotropin-releasing hormone analogues demonstrates high efficacy.
  • Surgical intervention shows low efficacy and high complication rates.

Impact:

  • Provides critical insights into the neuroanatomical basis of endocrine disorders in children.
  • Establishes medical treatment as the preferred, highly effective approach for precocious puberty due to hypothalamic hamartomas.
  • Highlights the risks associated with surgical intervention, guiding clinical decision-making.